Cysal Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 2
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $1.29M
Latest Deal Amount
  • Investors
  • 4

Cysal General Information


Developer of biotechnological products designed to provide assistance in the production of dipeptides. The company's products focus on developing, optimizing and licensing microbial metabolic diversity and fermentation processes for biopolymers and low-molecular weight compounds, enabling researchers to replace chemical approaches for the production of specialty and base commodities.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Mendelstraße 11
  • 48149 Münster
  • Germany
+49 0251 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cysal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 08-Nov-2012 $1.29M 00.000 00.000 Completed Generating Revenue
1. Grant Completed Generating Revenue
To view Cysal’s complete valuation and funding history, request access »

Cysal Executive Team (3)

Name Title Board Seat Contact Info
Ahmed Sallam Co-Founder, Chief Executive Officer and Chief Operating Officer
To view Cysal’s complete executive team members history, request access »

Cysal Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cysal Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
eCAPITAL entrepreneurial Partners Venture Capital Minority 000 0000 000000 0
Gründerfonds Münsterland Venture Capital Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
Federal Ministry for Economic Affairs and Energy Limited Partner 000 0000 000000 0
To view Cysal’s complete investors history, request access »